Literature DB >> 24637366

Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCA.

Sarah L Mackie1, Bhaskar Dasgupta2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24637366     DOI： 10.1038/nrrheum.2014.38

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Association between polymyalgia rheumatica and vascular disease: a systematic review.

Authors:  Adam T Hancock; Christian D Mallen; John Belcher; Samantha L Hider
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-09       Impact factor: 4.794

2.  Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.

Authors:  Aladdin J Mohammad; Jan-Åke Nilsson; Lennart T H Jacobsson; Peter A Merkel; Carl Turesson
Journal:  Ann Rheum Dis       Date:  2014-01-17       Impact factor: 19.103

3.  Th17 and Th1 T-cell responses in giant cell arteritis.

Authors:  Jiusheng Deng; Brian R Younge; Richard A Olshen; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

4.  Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.

Authors:  Jem Ninan; Anh-Minh Nguyen; Antonia Cole; Maureen Rischmueller; Thomas Dodd; Peter Roberts-Thomson; Catherine L Hill
Journal:  J Rheumatol       Date:  2011-08-15       Impact factor: 4.666

5.  Disease pattern in cranial and large-vessel giant cell arteritis.

Authors:  A Brack; V Martinez-Taboada; A Stanson; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1999-02

6.  Giant cell arteritis with or without aortitis at diagnosis. A retrospective study of 22 patients with longterm followup.

Authors:  Olivier Espitia; Antoine Néel; Christophe Leux; Jérome Connault; Alexandra Espitia-Thibault; Thierry Ponge; Benoit Dupas; Jacques H Barrier; Mohamed A Hamidou; Christian Agard
Journal:  J Rheumatol       Date:  2012-09-15       Impact factor: 4.666

7.  Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.

Authors:  Gunnar Tomasson; Christine Peloquin; Aladdin Mohammad; Thorvardur J Love; Yuqing Zhang; Hyon K Choi; Peter A Merkel
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

Review 8.  New treatment strategies in large-vessel vasculitis.

Authors:  Sebastian Unizony; John H Stone; James R Stone
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

9.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

10.  Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression.

Authors:  Suchita Nadkarni; Jesmond Dalli; Jane Hollywood; Justin C Mason; Bhaskar Dasgupta; Mauro Perretti
Journal:  Circ Res       Date:  2013-10-24       Impact factor: 17.367
  10 in total
  4 in total

Review 1.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983

Review 2.  The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease.

Authors:  Sophie Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  BMC Cardiovasc Disord       Date:  2016-10-28       Impact factor: 2.298

3.  Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Authors:  L K Brekke; B-T S Fevang; A P Diamantopoulos; J Assmus; E Esperø; C G Gjesdal
Journal:  Arthritis Res Ther       Date:  2019-06-25       Impact factor: 5.156

4.  Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Authors:  L K Brekke; A P Diamantopoulos; B-T Fevang; J Aβmus; E Esperø; C G Gjesdal
Journal:  Arthritis Res Ther       Date:  2017-12-15       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.